However, genomic mutations especially amplification of UPK1A gene was usually observed in various cancers, including uterine carcinosarcoma, Ovarian serous cystadenocarcinoma, lung cancer, pancreatic adenocarcinoma and HCC (Figure 1B). This evidence concerns the gene UPK1A and hepatocellular carcinoma.